Literature DB >> 22403258

Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells.

Xuguang Tai1, François Van Laethem, Leonid Pobezinsky, Terry Guinter, Susan O Sharrow, Anthony Adams, Larry Granger, Michael Kruhlak, Tullia Lindsten, Craig B Thompson, Lionel Feigenbaum, Alfred Singer.   

Abstract

CTLA-4 proteins contribute to the suppressor function of regulatory T cells (Tregs), but the mechanism by which they do so remains incompletely understood. In the present study, we assessed CTLA-4 protein function in both Tregs and conventional (Tconv) CD4(+) T cells. We report that CTLA-4 proteins are responsible for all 3 characteristic Treg functions of suppression, TCR hyposignaling, and anergy. However, Treg suppression and anergy only required the external domain of CTLA-4, whereas TCR hyposignaling required its internal domain. Surprisingly, TCR hyposignaling was neither required for Treg suppression nor anergy because costimulatory blockade by the external domain of CTLA-4 was sufficient for both functions. We also report that CTLA-4 proteins were localized in Tregs in submembrane vesicles that rapidly recycled to/from the cell surface, whereas CTLA-4 proteins in naive Tconv cells were retained in Golgi vesicles away from the cell membrane and had no effect on Tconv cell function. However, TCR signaling of Tconv cells released CTLA-4 proteins from Golgi retention and caused activated Tconv cells to acquire suppressor function. Therefore, the results of this study demonstrate the importance of intracellular localization for CTLA-4 protein function and reveal that CTLA-4 protein externalization imparts suppressor function to both regulatory and conventional CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403258      PMCID: PMC3369608          DOI: 10.1182/blood-2011-11-388918

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells.

Authors:  Namita Misra; Jagadeesh Bayry; Sébastien Lacroix-Desmazes; Michel D Kazatchkine; Srini V Kaveri
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

2.  Molecular basis of T cell inactivation by CTLA-4.

Authors:  K M Lee; E Chuang; M Griffin; R Khattri; D K Hong; W Zhang; D Straus; L E Samelson; C B Thompson; J A Bluestone
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

Review 3.  The emerging role of CTLA-4 as an immune attenuator.

Authors:  C B Thompson; J P Allison
Journal:  Immunity       Date:  1997-10       Impact factor: 31.745

4.  Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.

Authors:  Cecilia Oderup; Lukas Cederbom; Anna Makowska; Corrado M Cilio; Fredrik Ivars
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

5.  CTLA-4 can function as a negative regulator of T cell activation.

Authors:  T L Walunas; D J Lenschow; C Y Bakker; P S Linsley; G J Freeman; J M Green; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

6.  Characterization of CTLA-4 structure and expression on human T cells.

Authors:  T Lindsten; K P Lee; E S Harris; B Petryniak; N Craighead; P J Reynolds; D B Lombard; G J Freeman; L M Nadler; G S Gray
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

7.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Authors:  E A Tivol; F Borriello; A N Schweitzer; W P Lynch; J A Bluestone; A H Sharpe
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

8.  Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.

Authors:  L E Marengère; P Waterhouse; G S Duncan; H W Mittrücker; G S Feng; T W Mak
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

9.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

10.  CTLA-4 is a second receptor for the B cell activation antigen B7.

Authors:  P S Linsley; W Brady; M Urnes; L S Grosmaire; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  93 in total

Review 1.  [Pathophysiology of peritonitis].

Authors:  K Beyer; P Menges; W Keßler; C-D Heidecke
Journal:  Chirurg       Date:  2016-01       Impact factor: 0.955

2.  Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.

Authors:  Max A Cheng; Emily Farmer; Claire Huang; John Lin; Chien-Fu Hung; T-C Wu
Journal:  Hum Gene Ther       Date:  2018-03-16       Impact factor: 5.695

3.  Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3.

Authors:  Jeremy A Goettel; Subhabrata Biswas; Willem S Lexmond; Ada Yeste; Laura Passerini; Bonny Patel; Siyoung Yang; Jiusong Sun; Jodie Ouahed; Dror S Shouval; Katelyn J McCann; Bruce H Horwitz; Diane Mathis; Edgar L Milford; Luigi D Notarangelo; Maria-Grazia Roncarolo; Edda Fiebiger; Wayne A Marasco; Rosa Bacchetta; Francisco J Quintana; Sung-Yun Pai; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

4.  A Role for Regulatory T Cells in a Murine Model of Epicutaneous Toluene Diisocyanate Sensitization.

Authors:  Carrie Mae Long; Nikki B Marshall; Ewa Lukomska; Michael L Kashon; B Jean Meade; Hillary Shane; Stacey E Anderson
Journal:  Toxicol Sci       Date:  2016-04-21       Impact factor: 4.849

5.  In utero transplantation: Disparate ramifications.

Authors:  John S Pixley; Esmail D Zanjani
Journal:  World J Stem Cells       Date:  2013-04-26       Impact factor: 5.326

6.  Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice.

Authors:  Hyo Jin Park; Ji Hoon Oh; Sang-Jun Ha
Journal:  J Vis Exp       Date:  2016-06-22       Impact factor: 1.355

Review 7.  Immune checkpoint inhibitors for hepatocellular carcinoma.

Authors:  Christopher E Jensen; Arturo Loaiza-Bonilla; Paula A Bonilla-Reyes
Journal:  Hepat Oncol       Date:  2016-06-27

8.  High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.

Authors:  A Vallejo; M Abad-Fernández; S Moreno; A Moreno; M J Pérez-Elías; F Dronda; J L Casado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-21       Impact factor: 3.267

9.  Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.

Authors:  Patrizio Caturegli; Giulia Di Dalmazi; Martina Lombardi; Federica Grosso; H Benjamin Larman; Tatianna Larman; Giacomo Taverna; Mirco Cosottini; Isabella Lupi
Journal:  Am J Pathol       Date:  2016-10-15       Impact factor: 4.307

10.  Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.

Authors:  Yuning Lu; Helga Schneider; Christopher E Rudd
Journal:  Blood       Date:  2012-10-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.